Physician profile
Jade Resto
NPI 1386274447
$644.57
in general payments reported to CMS, 2019-2025
9 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $153 · 2023: $128 · 2024: $26.46 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.29 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $125.00 | 2021 | |
| Medtronic, INC. | $106.90 | 2023 | Cobalt Dr Mri Surescan, Micra |
| Abiomed | $96.28 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.67 | 2022 | |
| Aimmune Therapeutics, INC. | $70.64 | 2025 | Vowst |
| Spinal Simplicity, LLC | $65.25 | 2022 | |
| Amgen INC. | $55.76 | 2022-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $26.46 | 2024 | |
| Edwards Lifesciences Corporation | $22.61 | 2025 | Evoque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Resto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.